OnKure Therapeutics, Inc. (OKUR)
3.54
-0.02
(-0.56%)
USD |
NASDAQ |
Sep 02, 16:00
3.99
+0.45
(+12.71%)
Pre-Market: 08:13
OnKure Therapeutics Research and Development Expense (TTM) : 46.54M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.54M |
| March 31, 2026 | 46.53M |
| December 31, 2025 | 47.81M |
| September 30, 2025 | 74.14M |
| June 30, 2025 | 72.33M |
| March 31, 2025 | 70.47M |
| December 31, 2024 | 66.03M |
| September 30, 2024 | 37.62M |
| June 30, 2024 | 41.20M |
| March 31, 2024 | 44.92M |
| December 31, 2023 | 47.42M |
| September 30, 2023 | 49.12M |
| Date | Value |
|---|---|
| June 30, 2023 | 45.36M |
| March 31, 2023 | 39.11M |
| December 31, 2022 | 37.42M |
| September 30, 2022 | 34.27M |
| June 30, 2022 | 33.76M |
| March 31, 2022 | 31.92M |
| December 31, 2021 | 28.12M |
| September 30, 2021 | 26.14M |
| June 30, 2021 | 21.26M |
| March 31, 2021 | 17.80M |
| December 31, 2020 | 15.91M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Theriva Biologics, Inc. | 5.306M |
| Nkarta, Inc. | 89.88M |
| Unicycive Therapeutics, Inc. | 9.609M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |